| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/05/2008 | DE102006058183A1 Verwendung von Substanzen, die den zellulären Glutathion-Gehalt absenken, zur Herstellung eines Arzneimittels zur Behandlung von T-Zell vermittelten Autoimmunkrankheiten Use of substances which lower the cellular glutathione content, to prepare a medicament for the treatment of T cell mediated autoimmune diseases |
| 06/05/2008 | DE102006054654A1 Body-care and beauty-care product containing colloidal gold with vegetable oils and-or essential oils and-or biopolymers, used e.g. as a medicinal or non-medicinal food supplement |
| 06/05/2008 | CA2670445A1 Binding members for interleukin-6 |
| 06/04/2008 | EP1927598A1 Vaccine |
| 06/04/2008 | EP1927367A1 Novel pharmaceutical using anti-hla antibody |
| 06/04/2008 | EP1927366A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (RSV) |
| 06/04/2008 | EP1926813A2 Cell populations having immunoregulatory activity, method for isolation and uses |
| 06/04/2008 | EP1926750A2 Biological materials and uses thereof |
| 06/04/2008 | EP1592777A4 A method for generating high affinity antibodies |
| 06/04/2008 | EP1487817B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 06/04/2008 | EP1463754B1 Cystine-knot fold protein |
| 06/04/2008 | EP1322327B1 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 06/04/2008 | EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 06/04/2008 | EP1195162B1 Vaccine preparation containing fatty acid as a constituent |
| 06/04/2008 | EP1193250B1 Phenyl sulfamate derivatives |
| 06/04/2008 | EP1137436B1 Stimulation of T-cells against self antigens using CTLA-4 blocking agents |
| 06/04/2008 | EP0920505B1 Mammalian cell surface antigens; related reagents |
| 06/04/2008 | EP0672143B1 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/04/2008 | CN101190944A Human cytokine and use thereof |
| 06/04/2008 | CN101190330A Application of cholinesterase in antagonistic tachykinin medicine |
| 06/04/2008 | CN101190306A Compound composition with qi-complementing and spleen-invigorating function and preparation method and application thereof |
| 06/04/2008 | CN101190304A Health care capsule |
| 06/04/2008 | CN101190220A Chlorpheniramine maleate chewable tablets for dog or cat |
| 06/04/2008 | CN100391978C Recombinant anti-CD4 antibodies for human therapy |
| 06/04/2008 | CN100391977C Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 06/04/2008 | CN100391970C DNA sequence and recombinant production of the grass pollen allergen Phl p4 |
| 06/04/2008 | CN100391543C Non-viral gene delivery system |
| 06/04/2008 | CN100391542C Composition for delivering genes to antigen presenting cells of the skin and its use |
| 06/04/2008 | CN100391537C Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B |
| 06/04/2008 | CN100391492C Burdock microecological formulation |
| 06/04/2008 | CN100391478C Extracte of Aspongopus chinensis Dallas and Extraction method therefor medicinal use and preparation thereof |
| 06/04/2008 | CN100391476C Medicine composition for delaying senility and raising immunity and its preparation method |
| 06/04/2008 | CN100391465C Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic |
| 06/04/2008 | CN100391440C Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base |
| 06/04/2008 | CN100391439C Immunopotentiators |
| 06/03/2008 | US7381813 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand |
| 06/03/2008 | US7381807 Of given nucleotide sequence; encapsulated in slow release delivery vehicle; includes viral or bacterial antigen; increases cell proliferation, differentiation, cytokine and antibody production for lymphocytes |
| 06/03/2008 | US7381800 Antibodies to HBIMF63 polypeptide |
| 06/03/2008 | US7381795 Modified interferon beta with reduced immunogenicity |
| 06/03/2008 | US7381790 Copolymers for suppression of autoimmune diseases, and methods of use |
| 06/03/2008 | US7381702 Methods of treating diabetes mellitus |
| 06/03/2008 | US7381563 Treating peripherial blood mononuclear cells with a suppressive composition for a time sufficient to induce T cell tolerance; and introducing said cells to said patient. |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | US7381406 Probiotic lactobacillus strains for pets |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/03/2008 | CA2305760C Inhibitors of nucleoside metabolism |
| 06/03/2008 | CA2175215C Semisynthetic analogs of rapamycin (macrolides) being immunomodulators |
| 05/29/2008 | WO2008064274A1 Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses |
| 05/29/2008 | WO2008063996A2 Therapeutic targeting of escort proteins |
| 05/29/2008 | WO2008063776A2 Antibodies to lymphotoxin-alpha |
| 05/29/2008 | WO2008063213A2 Uses and compositions for treatment of psoriatic arthritis |
| 05/29/2008 | WO2008063116A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 05/29/2008 | WO2008062861A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 05/29/2008 | WO2008062699A1 Carrier |
| 05/29/2008 | WO2008061612A1 Use of arginase inhibitors in the treatment of asthma and allergic rhinitis |
| 05/29/2008 | WO2008040649A3 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 05/29/2008 | WO2008021532A3 Treatment of inflammatory diseases |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2008002611A3 Delta-tocotrienol treatment and prevention of pancreatic cancer |
| 05/29/2008 | WO2007074456A3 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 05/29/2008 | WO2007034210A8 Deglycosylated anti-muc-1 antibodies and uses thereof |
| 05/29/2008 | US20080125484 Synthetic Lactone Formulations and Methods of Use |
| 05/29/2008 | US20080125482 Stabilized ascorbic acid solutions; method of use thereof; process for their obtention; and compositions comprising the same |
| 05/29/2008 | US20080125457 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 05/29/2008 | US20080125446 For example, 6-amino-2-(chloro or fluoro)-8-(arylthio(oxo))-9H-purines; complex with Heat Shock Protein 90 (HSP 90); proliferative disorders such as breast cancer |
| 05/29/2008 | US20080125425 Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2badenosine receptors |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125417 4-Tert-Butyl-N-(2-methyl-3-{2-[4-(morpholine-4-carbonyl)-phenylamino]-pyrimidin-4-yl}-phenyl)-benzamide;enzyme inhibitors of Burton's tyrosine kinase (Btk); autoimmune diseases; antiinflammatory/-arthritic agents; X-linked agammaglobulinaemia; antiallergens; osteoporosis; determining the presence Btk |
| 05/29/2008 | US20080125404 purine and pyrimidine derivatives such as Roscovitine or 2-[(1-ethyl-2-hydroxyethyl)amino]-6-benzylamine-9-isopropylpurine or olomoucine or purvalanol A for treating human systemic lupus erythematosus associated with antinuclear antibodies; methylprednisolone |
| 05/29/2008 | US20080125378 Use of Amygdalin Analogues for the Treatment of Psoriasis |
| 05/29/2008 | US20080125369 Soluble t cell receptors |
| 05/29/2008 | US20080125365 Fibronectins; inflammation |
| 05/29/2008 | US20080125364 Increasing formation of tight junctions by modulating occludin activity of transformed cells (induced by RAF1) |
| 05/29/2008 | US20080125346 Infant Formula |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124413 Novel composition containing extracts of butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation hypersensitivity or pain |
| 05/29/2008 | US20080124408 includes an alkylamide fraction comprising a 2-ene alkylamide fraction and a 2,4-diene alkylamide fraction; for the prevention and treatment of colds and flu |
| 05/29/2008 | US20080124403 e.g., histone deacetylase inhibitor; includes electrolyte supplementation; to prevent unwanted side effects such as cardiac side effects |
| 05/29/2008 | US20080124396 polymer synthesized by a cross-coupling reaction of polymer scaffold units and xenoantigens |
| 05/29/2008 | US20080124390 Antidepressants for treating manic disorders, psychosis; comprising ethyl cellulose, talc, polyvinylpyrrolidone; time-release dosage form; once daily |
| 05/29/2008 | US20080124365 Using single-stranded DNA template to generate antisense RNA sequences for treatment and prevention of viral infection and cell proliferative disorders; viricides; antitumor agents |
| 05/29/2008 | US20080124358 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 05/29/2008 | US20080124356 Keratinocyte Culturing Method and the Use Thereof |
| 05/29/2008 | US20080124345 Human epidermal growth factor (HER) binding ligand for use in prevention and treatment of cell proliferative disorders |
| 05/29/2008 | US20080124341 Using immunoglobulin specific to viral transport protein associated with budding to prevent and treat viral diseases |
| 05/29/2008 | US20080124322 Activation and inhibition of the immune system |
| 05/29/2008 | US20080124313 Nucleotide sequences coding methionyl tRNA synthetase protein for use in identifying modulators for prevention and treatment of bacterial infection |
| 05/29/2008 | US20080124307 Method for promoting immunotherapy |
| 05/29/2008 | US20080124301 Oligonucleotide for use in prevention and treatment of cell proliferative and nervous system disorders; antisense agents |
| 05/29/2008 | US20080124278 characterized by a modification at the conserved N-linked site in the CH2 domains of the Fc portion of said antibody; useful in the treatment and prevention of diseases that involve undesirable immune responses |
| 05/29/2008 | US20080124275 Crystalline Form of Fatty Acid Amide Hydrolase (Faah) |
| 05/29/2008 | DE102006055210A1 Diätisches Lebensmittel mit erhöhter freie Radikale bindender Wirkung Dietary foods with increased free radical binding effect |
| 05/29/2008 | CA2677335A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 05/29/2008 | CA2673137A1 Prodrug salts of 2,4-pyrimidinediamine compounds and their uses |
| 05/29/2008 | CA2669300A1 Use of arginase inhibitors in the treatment of asthma and allergic rhinitis |
| 05/29/2008 | CA2669124A1 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 05/29/2008 | CA2669104A1 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
| 05/29/2008 | CA2665644A1 Antibodies to lymphotoxin-alpha |
| 05/28/2008 | EP1925662A1 Recombinant Poxvirus-Cytomegalovirus Compositions and uses |